These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 38748928

  • 41. Impact of provider mailings on medication adherence by Medicare Part D members.
    Borah BJ, Qiu Y, Shah ND, Gleason PP.
    Healthc (Amst); 2016 Sep; 4(3):207-16. PubMed ID: 27637828
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Medicare Star excludes diabetes patients with poor CVD risk factor control.
    Schmittdiel J, Raebel M, Dyer W, Steiner J, Goodrich G, Karter A, Nichols G.
    Am J Manag Care; 2014 Dec 01; 20(12):e573-81. PubMed ID: 25741874
    [Abstract] [Full Text] [Related]

  • 44. Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders.
    Raebel MA, Ellis JL, Carroll NM, Bayliss EA, McGinnis B, Schroeder EB, Shetterly S, Xu S, Steiner JF.
    J Gen Intern Med; 2012 Jan 01; 27(1):57-64. PubMed ID: 21879374
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Association of medication adherence quality measures for diabetes, hypertension, and hyperlipidemia with cognitive decline.
    Racsa PN, Booth TA, Chung LN, Dixon SW, Poonawalla IB.
    J Family Med Prim Care; 2023 Nov 01; 12(11):2667-2675. PubMed ID: 38186814
    [Abstract] [Full Text] [Related]

  • 47. Evaluation of community pharmacist-provided telephone interventions to improve adherence to hypertension and diabetes medications.
    Stanton-Robinson C, Al-Jumaili AA, Jackson A, Catney C, Veach S, Witry MJ.
    J Am Pharm Assoc (2003); 2018 Nov 01; 58(4S):S120-S124. PubMed ID: 29891173
    [Abstract] [Full Text] [Related]

  • 48. Effect of Medicaid Policy Changes on Medication Adherence: Differences by Baseline Adherence.
    Amin K, Farley JF, Maciejewski ML, Domino ME.
    J Manag Care Spec Pharm; 2017 Mar 01; 23(3):337-345. PubMed ID: 28230447
    [Abstract] [Full Text] [Related]

  • 49. Estimating the economic impact of blister-packaging on medication adherence and health care costs for a Medicare Advantage health plan.
    Borrelli EP, Saad P, Barnes N, Dumitru D, Lucaci JD.
    J Manag Care Spec Pharm; 2024 Dec 01; 30(12):1442-1454. PubMed ID: 39258999
    [Abstract] [Full Text] [Related]

  • 50. A Pharmacist Telephone Intervention to Identify Adherence Barriers and Improve Adherence Among Nonadherent Patients with Comorbid Hypertension and Diabetes in a Medicare Advantage Plan.
    Abughosh SM, Wang X, Serna O, Henges C, Masilamani S, Essien EJ, Chung N, Fleming M.
    J Manag Care Spec Pharm; 2016 Jan 01; 22(1):63-73. PubMed ID: 27015053
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Trajectories of Diabetes Medication Adherence and Hospitalization Risk: A Retrospective Cohort Study in a Large State Medicaid Program.
    Lo-Ciganic WH, Donohue JM, Jones BL, Perera S, Thorpe JM, Thorpe CT, Marcum ZA, Gellad WF.
    J Gen Intern Med; 2016 Sep 01; 31(9):1052-60. PubMed ID: 27229000
    [Abstract] [Full Text] [Related]

  • 55. Medication Adherence, Health Care Utilization, and Costs Among Patients Initiating Oral Oncolytics for Multiple Myeloma or Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Dashputre AA, Gatwood KS, Gatwood J.
    J Manag Care Spec Pharm; 2020 Feb 01; 26(2):186-196. PubMed ID: 32011965
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
    Benner JS, Chapman RH, Petrilla AA, Tang SS, Rosenberg N, Schwartz JS.
    Am J Health Syst Pharm; 2009 Aug 15; 66(16):1471-7. PubMed ID: 19667004
    [Abstract] [Full Text] [Related]

  • 60. The Effect of Age and Comorbidities on the Association Between the Medicare STAR Oral Antihyperglycemic Adherence Metric and Glycemic Control.
    Nichols GA, Raebel MA, Dyer W, Schmittdiel JA.
    J Manag Care Spec Pharm; 2018 Sep 15; 24(9):856-861. PubMed ID: 30156449
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.